The Global Spina Bifida market is forecast to reach USD 3.90 Billion by 2027, according to a new report by Reports and Data. Spina bifida [SB], in literal terms, implies “cleft spine,” which characterizes incomplete development of spinal cord, brain, and/or meninges. There remains limited certainty regarding the cause for the occurrence of the condition. However, a combination of factors like nutritional, and environmental risk factors like folate (vitamin B-9) deficiency and nutrition are considered as the cause for the occurrence of the condition. Factors like obesity before, diabetes, and folate deficiency are considered as risk factors for the occurrence of the condition. The severity of the condition can be established with the help of the fact that, in the U.S, 1,500 to 2,000 of the more than 4 million babies born are effected by the condition every year. In the U.S., approximately 166,000 individuals are living with SB. It is more common among the population with fair complexion, Hispanics. It is more commonly observed among women as compared to men. The high incidence rate of the condition acts as one of the major factors propelling the market growth. Technological advancements in the healthcare sector is also supporting the market growth. Technological developments like 3D Printing contributes in the advancements in minimally invasive SB treatment, wherein the surgical procedure is combined with the technology, and with its help, doctors would be able to close off the spinal opening using a durable seal.
In regards to region, Europe is expected to occupy a considerable share of the market. The market share held by the region is attributed to the continuously growing healthcare sector, supportive reimbursement policies, and government support towards RD activities.
In-depth Study of the Competitive Landscape:
The global Spina Bifida market consists of various market players, which make this business sphere highly competitive. In this section of the report, the authors have provided authentic information on product portfolios, new product innovations, technological capabilities, and product pricing strategies of each of these players. Moreover, it discusses the key strategies implemented by these players, such as mergers acquisitions, joint ventures, collaborations, partnerships and agreements, to build on their market presence.
Top companies profiled in the report include:
C. R. Bard, Inc., Boston Scientific, B. Braun Melsungen AG, C. B. Fleet, Covidien Private Ltd., Cook Medical, Fujifilm, Medline Industries, KARL STORZ, Olympus Corporation, and Medtronic.
Disease Type Outlook (Revenue, USD Billion; 2016-2027)
- Myelomeningocele
- Occulta
- Closed neural tube defects
- Meningocele
Treatment Outlook (Revenue, USD Billion; 2016-2027)
- Medical procedures
- Surgeries
- Oral Medications
- Others
Diagnosis Outlook (Revenue, USD Billion; 2016-2027)
- Ultrasound
- Blood tests
- Amniocentesis
- Others
End-user Outlook (Revenue, USD Billion; 2016-2027)
- Hospital
- Clinics
- Diagnostic centers
- Pharmacies
- Others
Key Market Regions Covered in the Report:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Frequently asked questions addressed in the report:
- What is the revenue growth rate of the global Spina Bifida market over the forecast period?
- What are the major factors driving the growth of the Global Spina Bifida Market?
- What are the key challenges impacting the global Spina Bifida market growth?
- What are the outcomes of the SWOT Analysis and Porter’s Five Forces Analysis conducted in the report?
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2577
Thank you for reading our report. Do connect with us in case of any more queries about the report and its customization. Our team will ensure the report is well suited to cater to your needs.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
